(D-Arg1,D-Phe5,D-Trp7·9,Leu11)-Substance P is a modified substance P analog with D-arginine, D-phenylalanine, and D-tryptophan substitutions, which enhance receptor binding and stability. The peptide modulates neurogenic inflammation and pain transmission. Researchers use it to study the effects of substance P on pain pathways, neurogenic inflammation, and receptor dynamics across various tissues.
CAT No: G04014
CAS No:96736-12-8
Synonyms/Alias:96736-12-8;rPKPfQwFwLL-NH2;[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P;Antagonist D;MFCD00076802;CHEMBL501261;RPKPFQWFWLL;D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2;(D-Arg1,D-Phe5,D-Trp7.9,Leu11)-Substance P;[D-Arg1, D-Phe5, D-Trp7,9, Leu11]-Substance P;L-Leucinamide,D-arginyl-L-prolyl-L-lysyl-L-prolyl-D-phenylalanyl-L-glutaminyl-D-tryptophyl-L-phenylalanyl-D-tryptophyl-L-leucyl-;BDBM50260268;AKOS024456872;FA109992;HY-103544;CS-0028072;(D-Arg1,D-Phe5,D-Trp7?9,Leu11)-Substance P;[D-Arg1, D-Phe5, D-Trp7,9, Leu11]-Substance P, >=95% (HPLC);D-Arg(1)-Pro(2)-Lys(3)-Pro(4)-D-Phe(5)-Gln(6)-D-Trp(7)-Phe(8)-D-Trp(9)-Leu(10)-Leu(11)-NH(2);H-D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2; H-(dR)PKP(dF)Q(dW)F(dW)LL-NH2;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.